Zenith Epigenetics Commences Operations

News   Jun 05, 2013

 
Zenith Epigenetics Commences Operations
 
 
 

RELATED ARTICLES

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

Vaccine to One Hemorrhagic Virus Could Protect Against Others

News

Scientists report that antibodies made in response to a vaccine against one hemorrhagic fever virus—Junin—can successfully disarm one of its cousins, Machupo, for which there’s currently no vaccine.

READ MORE

Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine

News

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE